New Deal Advisors supports Favillin in the acquisition of Interpack
Milan, January 27 2025 – New Deal Advisors, an independent company specialising advisory services to M&A Transactions, has supported Favillini Pharmaceutical Packaging Group S.p.A., a paper manufacturer focused on the production of secondary packaging for the pharmaceutical and nutraceutical industry controlled by Arcadia Sgr, in the acquisition of Interpack S.p.A.
Interpack, controlled by Oxy Capital through Gpack, is a graphics-cartotechnology company specialised in the production of packaging material for the pharmaceutical industry based in Pomezia. Since 2020, following the entry of Arcadia Sgr in its shareholding, Favillini has undertaken a process of growth both organically and through external lines, with the aim of consolidating the fragmented Italian pharmaceutical and nutraceutical packaging market. With the acquisition of Interpack, Favillini now completes its strategic coverage of the Italian market, consolidating its position as a leader in the production of secondary packaging for the pharmaceutical and nutraceutical sectors. With an annual production of around 850 million pieces, the group expects to achieve a consolidated turnover of more than €45 million in 2025, spread over three production plants.
New Deal Advisors with a team led by Guido Pelissero, (partner), has provided financial due diligence services to Favillini.
***
New Deal Advisors is an independent firm specialising in advisory services in M&A. Established in 2012, New Deal Advisors provides support in a broad variety of extraordinary transactions streams including mergers and acquisitions, restructuring, transformation processes, forensic and litigation activities, fairness opinions and valuation services. New Deal Advisors has worked for more than a decade alongside private equity funds, investment holdings, family offices, financial institutions and strategic players achieving to date the finalisation of over 200 deals.